Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Pulmonary Medicine
Published in: BMC Pulmonary Medicine 1/2014

Open Access 01-12-2014 | Study protocol

Taking Healthy Steps: rationale, design and baseline characteristics of a randomized trial of a pedometer-based internet-mediated walking program in veterans with chronic obstructive pulmonary disease

Authors: Carlos H Martinez, Marilyn L Moy, Huong Q Nguyen, Miriam Cohen, Reema Kadri, Pia Roman, Robert G Holleman, Hyungjin Myra Kim, David E Goodrich, Nicholas D Giardino, Caroline R Richardson

Published in: BMC Pulmonary Medicine | Issue 1/2014

Login to get access

Abstract

Background

Low levels of physical activity are common in patients with chronic obstructive pulmonary disease (COPD), and a sedentary lifestyle is associated with poor outcomes including increased mortality, frequent hospitalizations, and poor health-related quality of life. Internet-mediated physical activity interventions may increase physical activity and improve health outcomes in persons with COPD.

Methods/Design

This manuscript describes the design and rationale of a randomized controlled trial that tests the effectiveness of Taking Healthy Steps, an Internet-mediated walking program for Veterans with COPD. Taking Healthy Steps includes an uploading pedometer, a website, and an online community. Eligible and consented patients wear a pedometer to obtain one week of baseline data and then are randomized on a 2:1 ratio to Taking Healthy Steps or to a wait list control. The intervention arm receives iterative step-count feedback; individualized step-count goals, motivational and informational messages, and access to an online community. Wait list controls are notified that they are enrolled, but that their intervention will start in one year; however, they keep the pedometer and have access to a static webpage.

Discussion

Participants include 239 Veterans (mean age 66.7 years, 93.7% male) with 155 randomized to Taking Healthy Steps and 84 to the wait list control arm; rural-living (45.2%); ever-smokers (93.3%); and current smokers (25.1%). Baseline mean St. George’s Respiratory Questionnaire Total Score was 46.0; 30.5% reported severe dyspnea; and the average number of comorbid conditions was 4.9. Mean baseline daily step counts was 3497 (+/- 2220).
Veterans with COPD can be recruited to participate in an online walking program. We successfully recruited a cohort of older Veterans with a significant level of disability including Veterans who live in rural areas using a remote national recruitment strategy.

Trial registration

Clinical Trials.gov NCT01102777
Appendix
Available only for authorised users
Literature
1.
Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006, 28: 523-532. 10.1183/09031936.06.00124605.CrossRefPubMed
2.
Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E: International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007, 370: 741-750. 10.1016/S0140-6736(07)61377-4.CrossRefPubMed
3.
Centers for Disease Control Prevention: Deaths from chronic obstructive pulmonary disease--United States, 2000–2005. MMWR Morb Mortal Wkly Rep. 2008, 57: 1229-1232.
4.
Sharafkhaneh A, Petersen NJ, Yu HJ, Dalal AA, Johnson ML, Hanania NA: Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010, 5: 125-132.PubMedPubMedCentral
5.
Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002, 57: 847-852. 10.1136/thorax.57.10.847.CrossRefPubMedPubMedCentral
6.
Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H, Murio C, Ros F, Vidal R: Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004, 59: 387-395. 10.1136/thx.2003.008730.CrossRefPubMedPubMedCentral
7.
Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010, 363: 1128-1138. 10.1056/NEJMoa0909883.CrossRefPubMed
8.
Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000, 320: 1297-1303. 10.1136/bmj.320.7245.1297.CrossRefPubMedPubMedCentral
9.
Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, Ohlsson SV: Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European respiratory society study on chronic obstructive pulmonary disease. N Engl J Med. 1999, 340: 1948-1953. 10.1056/NEJM199906243402503.CrossRefPubMed
10.
Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP: Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009, 374: 1171-1178. 10.1016/S0140-6736(09)61298-8.CrossRefPubMed
11.
Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J: Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res. 2009, 10: 59-10.1186/1465-9921-10-59.CrossRefPubMedPubMedCentral
12.
Jones PW: Health status and the spiral of decline. COPD. 2009, 6: 59-63. 10.1080/15412550802587943.CrossRefPubMed
13.
Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP: Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009, 180: 948-955. 10.1164/rccm.200906-0876OC.CrossRefPubMed
14.
Martinez CH, Han MK: Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes. Med Clin North Am. 2012, 96: 713-727. 10.1016/j.mcna.2012.02.007.CrossRefPubMedPubMedCentral
15.
Effing TW, Bourbeau J, Vercoulen J, Apter AJ, Coultas D, Meek P, Valk P, Partridge MR, Palen J: Self-management programmes for COPD: moving forward. Chron Respir Dis. 2012, 9: 27-35. 10.1177/1479972311433574.CrossRefPubMed
16.
Watz H, Waschki B, Meyer T, Magnussen H: Physical activity in patients with COPD. Eur Respir J. 2009, 33: 262-272.CrossRefPubMed
17.
Pitta F, Breyer MK, Hernandes NA, Teixeira D, Sant’Anna TJ, Fontana AD, Probst VS, Brunetto AF, Spruit MA, Wouters EF, Burghuber OC, Hartl S: Comparison of daily physical activity between COPD patients from Central Europe and South America. Respir Med. 2009, 103: 421-426. 10.1016/j.rmed.2008.09.019.CrossRefPubMed
18.
Lehouck A, Boonen S, Decramer M, Janssens W: COPD, bone metabolism, and osteoporosis. Chest. 2011, 139: 648-657. 10.1378/chest.10-1427.CrossRefPubMed
19.
Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, Moxham J, Polkey MI: A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res. 2007, 8: 25-10.1186/1465-9921-8-25.CrossRefPubMedPubMedCentral
20.
Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, Boyd C: The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med. 2012, 12: 26-10.1186/1471-2466-12-26.CrossRefPubMedPubMedCentral
21.
Moy ML, Teylan M, Weston NA, Gagnon DR, Garshick E: Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One. 2013, 8: e60400-10.1371/journal.pone.0060400.CrossRefPubMedPubMedCentral
22.
Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, Magnussen H: Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011, 140: 331-342. 10.1378/chest.10-2521.CrossRefPubMed
23.
Moy ML, Teylan M, Weston NA, Gagnon DR, Danilack VA, Garshick E: Daily step count is associated with plasma CRP and IL-6 in a US cohort with COPD. Chest. 2013, doi: 10.1378/chest.13-1052. [Epub ahead of print]
24.
Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C: Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007, 131 (Suppl 5): S4-42.CrossRef
25.
Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J: Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011, CD005305-doi: 10.1002/14651858.CD005305.pub3. Review, 10
26.
Ries AL, Kaplan RM, Myers R, Prewitt LM: Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med. 2003, 167: 880-888. 10.1164/rccm.200204-318OC.CrossRefPubMed
27.
Martinez CH, Raparla S, Plauschinat CA, Giardino ND, Rogers B, Beresford J, Bentkover JD, Schachtner-Appel A, Curtis JL, Martinez FJ, Han MK: Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health (Larchmt). 2012, 21: 1267-1274. 10.1089/jwh.2012.3650.CrossRef
28.
Fischer MJ, Scharloo M, Abbink JJ, Thijs-Van A, Rudolphus A, Snoei L, Weinman JA, Kaptein AA: Participation and drop-out in pulmonary rehabilitation: a qualitative analysis of the patient’s perspective. Clin Rehabil. 2007, 21: 212-221. 10.1177/0269215506070783.CrossRefPubMed
29.
Abrams TE, Vaughan-Sarrazin M, Fan VS, Kaboli PJ: Geographic isolation and the risk for chronic obstructive pulmonary disease-related mortality: a cohort study. Ann Intern Med. 2011, 155: 80-86. 10.7326/0003-4819-155-2-201107190-00003.CrossRefPubMed
30.
Goodridge D, Lawson J, Rennie D, Marciniuk D: Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life. Rural Remote Health. 2010, 10: 1349-PubMed
31.
Thorpe O, Johnston K, Kumar S: Barriers and enablers to physical activity participation in patients with COPD: a systematic review. J Cardiopulm Rehabil Prev. 2012, 32: 359-369. 10.1097/HCR.0b013e318262d7df.CrossRefPubMed
32.
Johnston K, Grimmer-Somers K: Pulmonary rehabilitation: overwhelming evidence but lost in translation?. Physiother Can. 2010, 62: 368-373. 10.3138/physio.62.4.368.CrossRefPubMedPubMedCentral
33.
Nguyen HQ, Carrieri-Kohlman V, Rankin SH, Slaughter R, Stulbarg MS: Is Internet-based support for dyspnea self-management in patients with chronic obstructive pulmonary disease possible? Results of a pilot study. Heart Lung. 2005, 34: 51-62. 10.1016/j.hrtlng.2004.06.005.CrossRefPubMed
34.
Borycki E: M-health: can chronic obstructive pulmonary disease patients use mobile phones and associated software to self-manage their disease?. Stud Health Technol Inform. 2012, 172: 79-84.PubMed
35.
Moy ML, Janney AW, Nguyen HQ, Matthess KR, Cohen M, Garshick E, Richardson CR: Use of pedometer and internet-mediated walking program in patients with chronic obstructive pulmonary disease. J Rehabil Res Dev. 2010, 47: 485-496. 10.1682/JRRD.2009.07.0091.CrossRefPubMedPubMedCentral
36.
Moy ML, Weston NA, Wilson EJ, Hess ML, Richardson CR: A pilot study of an internet walking program and pedometer in COPD. Respir Med. 2012, 106: 1342-1350. 10.1016/j.rmed.2012.06.013.CrossRefPubMed
37.
The self-regulation of health and illness behavior. Edited by: Cameron L, Leventhal H. 2003, London: Routledge
38.
Handbook of self-regulation. Edited by: Boekaerts M, Pintrich P, Zeidner M. 2000, San Diego: Academic Press
39.
Locke E, Latham G: A theory of goalsetting and task performance. 1990, Englewoods Cliff: Prentice-Hall
40.
Richardson CR, Mehari KS, McIntyre LG, Janney AW, Fortlage LA, Sen A, Strecher VJ, Piette JD: A randomized trial comparing structured and lifestyle goals in an internet-mediated walking program for people with type 2 diabetes. Int J Behav Nutr Phys Act. 2007, 4: 59-10.1186/1479-5868-4-59.CrossRefPubMedPubMedCentral
41.
Cooke CR, Joo MJ, Anderson SM, Lee TA, Udris EM, Johnson E, Au DH: The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res. 2011, 11: 37-10.1186/1472-6963-11-37.CrossRefPubMedPubMedCentral
42.
43.
Krein SL, Metreger T, Kadri R, Hughes M, Kerr EA, Piette JD, Kim HM, Richardson CR: Veterans walk to beat back pain: study rationale, design and protocol of a randomized trial of a pedometer-based internet mediated intervention for patients with chronic low back pain. BMC Musculoskelet Disord. 2010, 11: 205-10.1186/1471-2474-11-205.CrossRefPubMedPubMedCentral
44.
Holbrook EA, Barreira TV, Kang M: Validity and reliability of Omron pedometers for prescribed and self-paced walking. Med Sci Sports Exerc. 2009, 41: 670-674. 10.1249/MSS.0b013e3181886095.CrossRefPubMed
45.
Danilack VA, Weston NA, Richardson CR, Mori DL, Moy ML: Reasons persons with COPD do not walk and relationship with daily step count. COPD. 2013, [Epub ahead of print]
46.
Richardson CR, Brown BB, Foley S, Dial KS, Lowery JC: Feasibility of adding enhanced pedometer feedback to nutritional counseling for weight loss. J Med Internet Res. 2005, 7: e56-10.2196/jmir.7.5.e56.CrossRefPubMedPubMedCentral
47.
Resnick PJ, Janney AW, Buis LR, Richardson CR: Adding an online community to an internet-mediated walking program. Part 2: strategies for encouraging community participation. J Med Internet Res. 2010, 12: e72-10.2196/jmir.1339.CrossRefPubMedPubMedCentral
48.
Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George’s respiratory questionnaire. Am Rev Respir Dis. 1992, 145: 1321-1327. 10.1164/ajrccm/145.6.1321.CrossRefPubMed
49.
Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR: Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil. 2007, 86: 30-36. 10.1097/PHM.0b013e31802b8eca.CrossRefPubMed
50.
Mortensen EM, Copeland LA, Pugh MJ, Restrepo MI, de Molina RM, Nakashima B, Anzueto A: Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res. 2009, 10: 45-10.1186/1465-9921-10-45.CrossRefPubMedPubMedCentral
51.
Joo MJ, Au DH, Fitzgibbon ML, Lee TA: Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respir Med. 2010, 104: 246-252. 10.1016/j.rmed.2009.10.002.CrossRefPubMed
52.
Cannon KT, Sarrazin MV, Rosenthal GE, Curtis AE, Thomas KW, Kaldjian LC: Use of mechanical and noninvasive ventilation in black and white chronic obstructive pulmonary disease patients within the veterans administration health care system. Med Care. 2009, 47: 129-133. 10.1097/MLR.0b013e3181809150.CrossRefPubMed
53.
Mahler DA, Ward J, Waterman LA, Baird JC: Longitudinal changes in patient-reported dyspnea in patients with COPD. COPD. 2012, 9: 522-527. 10.3109/15412555.2012.701678.CrossRefPubMed
54.
Mahler DA, Waterman LA, Ward J, McCusker C, ZuWallack R, Baird JC: Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest. 2007, 132: 1283-1290. 10.1378/chest.07-0703.CrossRefPubMed
55.
Jones PW: Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002, 19: 398-404. 10.1183/09031936.02.00063702.CrossRefPubMed
56.
Finnerty JP, Keeping I, Bullough I, Jones J: The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. Chest. 2001, 119: 1705-1710. 10.1378/chest.119.6.1705.CrossRefPubMed
57.
Elci A, Borekci S, Ovayolu N, Elbek O: The efficacy and applicability of a pulmonary rehabilitation programme for patients with COPD in a secondary-care community hospital. Respirology. 2008, 13: 703-707. 10.1111/j.1440-1843.2008.01327.x.CrossRefPubMed
58.
Jones P, Lareau S, Mahler DA: Measuring the effects of COPD on the patient. Respir Med. 2005, 99 (Suppl B): S11-18.CrossRefPubMed
59.
Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA: Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011, 26: 783-790. 10.1007/s11606-010-1629-x.CrossRefPubMedPubMedCentral
60.
Metadata
Title
Taking Healthy Steps: rationale, design and baseline characteristics of a randomized trial of a pedometer-based internet-mediated walking program in veterans with chronic obstructive pulmonary disease
Authors
Carlos H Martinez
Marilyn L Moy
Huong Q Nguyen
Miriam Cohen
Reema Kadri
Pia Roman
Robert G Holleman
Hyungjin Myra Kim
David E Goodrich
Nicholas D Giardino
Caroline R Richardson
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2014
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-14-12

Other articles of this Issue 1/2014

BMC Pulmonary Medicine 1/2014 Go to the issue

Research article

Prognosis of patients with suspected pulmonary embolism in Buenos Aires: a prospective cohort study

Research article

Sleep-related breathing disorders and gait variability: a cross-sectional preliminary study

Study protocol

The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markers

Study protocol

Comparison between breathing and aerobic exercise on clinical control in patients with moderate-to-severe asthma: protocol of a randomized trial

Study protocol

The PROTECCT-M study: a cohort study investigating associations between novel specific biomarkers, patient-related, healthcare system markers and the trajectory of COPD patients treated in primary care

Research article

Longterm follow-up in European respiratory health studies – patterns and implications
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits